Our results showed that MeCP2 expression was higher in 5-FU-resistant GC cells than in regular GC cells, and silencing MeCP2 inhibited cell proliferation, blocked the cell cycle to G1-S phase, and promoted cell apoptosis of 5-FU-resistant GC cells. The gene discussed is MECP2; the disease is gastric cancer.